CAW
GMAB icon

Cornerstone Advisors (Washington)’s Genmab GMAB Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$67K Buy
1,830
+72
+4% +$2.6K 0.01% 227
2020
Q2 		$60K Buy
1,758
+525
+43% +$14.3K 0.01% 234
2020
Q1 		$26K Buy
1,233
+22
+2% +$490 ﹤0.01% 304
2019
Q4 		$27K Buy
1,211
+210
+21% +$4.58K ﹤0.01% 316
2019
Q3 		$20K Buy
+1,001
New +$19.7K ﹤0.01% 335

Other funds holding GMAB

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Cornerstone Advisors (Washington)'s GMAB Position: Q3 2020 in Review

Cornerstone Advisors (Washington) increased its Genmab (GMAB) stake by 4.1% in Q3 2020, buying an estimated $2.6K and bringing the position to 1,830 shares worth $67K. The position accounts for 0.01% of the portfolio, ranked #227.

Cornerstone Advisors (Washington) first reported a position in GMAB in Q3 2019 and has held it in 5 quarters since. 199 funds tracked by Wall St. Rank hold GMAB as of Q3 2020.

  • Cornerstone Advisors (Washington) held 1,830 shares of Genmab worth $67K as of Q3 2020.
  • Cornerstone Advisors (Washington) bought 72 Genmab shares in Q3 2020, an estimated $2.6K.
  • Genmab made up 0.01% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #227 holding.
  • Cornerstone Advisors (Washington) first reported a position in Genmab in Q3 2019 and has held it in 5 quarters since.
  • 199 funds tracked by Wall St. Rank held Genmab as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.